Similar Articles
1751 Transjugular intrahepatic portosystemic shunt with covered stents for hepatocellular carcinoma with portal vein tumor thrombosis
1752 Novel hepatocellular carcinoma molecules with prognostic and therapeutic potentials
1753 Combination of chemotherapy and immunotherapy for colon cancer in China: A meta-analysis
1754 Meta-analysis of immunohistochemical expression of hypoxia inducible factor-1α as a prognostic role in gastric cancer
1755 Radiofrequency ablation as treatment for pulmonary metastasis of colorectal cancer
1756 Management of hepatocellular carcinoma: The role of contrast-enhanced ultrasound
1757 Predictors of survival in patients with established cirrhosis and hepatocellular carcinoma treated with sorafenib
1758 Bortezomib effect on E2F and cyclin family members in human hepatocellular carcinoma cell lines
1759 Intraductal endoscopic radiofrequency ablation for the treatment of hilar non-resectable malignant bile duct obstruction
1760 Epigenetics in hepatocellular carcinoma: An update and future therapy perspectives
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA